News

The company took this step in response to an appeal made by the UN and WHO to drug makers to save some of their pandemic vaccines for poor

Luciano Rossetti of Merck Research Laboratories, said: “Merck is pleased that we are now able to supply Tredaptive in approved markets and continue our long-standing commitment to help

Now the government intends to raise the volume figure to 30% over the next three years. This has motivated many major overseas generics players to start operations in

According to the company sources, the new product, an injection formulation of the Juvidex active ingredient M6P will be used in the treatment for tendon adhesions, and the

The company further plans to start a development program to examine the investigational product as an oral treatment for male hypogonadism, also known as low testosterone (low T).

For the third quarter of fiscal 2009, the company reported product revenue of $9,174,000 for the third quarter of fiscal 2009, a 12.7% increase, compared with $8,139,000 in

This crucial phase III clinical trial is designed to evaluate the effectiveness and safety of lubiprostone in Japanese patients with CIC over a 28-day treatment period. This trial

The 13,000 square feet primary and secondary trial packaging unit that expands the active pharmaceutical ingredient (API) site in Morpeth, Humberside, will serve as one stop shop for

The states which are up against Wyeth are California, Delaware, the District of Columbia, Florida, Illinois, Indiana, Louisiana, Massachusetts, Michigan, New Hampshire, New York, Nevada, Tennessee, Texas, Virginia,